Featured CME Activity
How Would You Treat This Patient?
Faculty Spotlight
“I think this is the time to review everything and make sure your NGS panel is broad and has covered all the new agents and new targets that are in development. Is there an opportunity there for a clinical trial strategy? Readdress goals of care and have a real discussion about our options and how we move forward.” Ticiana Leal, MD
Ticiana Leal, MD, is the Director of the Thoracic Medical Oncology Program and an Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine and Winship Cancer Institute. She specializes in the treatment of patients with lung cancer, mesothelioma, and thymic malignancies. Dr. Leal’s research centers around clinical trials investigating chemotherapy and immunotherapy agents for lung cancer. She has authored or coauthored numerous peer-reviewed articles, posters, and book chapters.
“It's great to talk about how good all these drugs are, but what if they're completely intolerable? Luckily, that’s not the case. Generally, immunotherapy has been a very relatively tolerable treatment for patients.”Beth Sandy, MSN, CRNP
Beth Sandy, MSN, CRNP, is an Outpatient Thoracic Oncology Nurse Practitioner at the University of Pennsylvania Abramson Cancer Center in Philadelphia, Pennsylvania. She specializes in the treatment and supportive care of patients with lung cancer and other thoracic malignancies. Ms. Sandy has authored or coauthored numerous peer-reviewed publications, posters, and book chapters, and has been a speaker at several national and international conferences.
Podcast
Earn CME | NCPD | CPE on the go by listening to this accredited activity as a podcast. Click HERE to start listening now!
Additional Resources
For additional information and unique perspectives on Non-Small Cell Lung Cancer and patient care, check out the expert interviews listed below.
